• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Structural modification study of bis(substituted aminoalkylamino)anthraquinones. An evaluation of the relationship of the [2-[(2-hydroxyethyl)amino]ethyl]amino side chain with antineoplastic activity.

作者信息

Zee-Cheng R K, Podrebarac E G, Menon C S, Cheng C C

出版信息

J Med Chem. 1979 May;22(5):501-5. doi: 10.1021/jm00191a008.

DOI:10.1021/jm00191a008
PMID:458801
Abstract

Several anthraquinones containing the [2-[(2-hydroxyethyl)amino]ethyl]amino, the [2-(dimethylamino)ethyl]amino, and the 2-(dimethylamino)ethoxy groups were prepared. Preparation of a lucanthone analogue, a 7-chloroquinoline derivative, and derivatives of naphthoquinones containing the [2-[(2-hydroxyethyl)amino]ethyl]amino side chain and related amino-substituted side chains was also conducted. It was found that the antineoplastic activity of anthraquinones containing the [2-[(2-hydroxyethyl)amino]ethyl]amino side chain is superior to those containing the tertiary amino side chain. However, the presence of the [2-[(2-hydroxyethyl)amino]ethyl]amino chain is an important, but not a sufficient, factor for good antineoplastic activity, as indicated by the lack of significant biological activity of other ring systems containing this side chain.

摘要

相似文献

1
Structural modification study of bis(substituted aminoalkylamino)anthraquinones. An evaluation of the relationship of the [2-[(2-hydroxyethyl)amino]ethyl]amino side chain with antineoplastic activity.
J Med Chem. 1979 May;22(5):501-5. doi: 10.1021/jm00191a008.
2
Antineoplastic agents. Structure-activity relationship study of bis(substituted aminoalkylamino)anthraquinones.
J Med Chem. 1978 Mar;21(3):291-4. doi: 10.1021/jm00201a012.
3
Structural modification study of mitoxantrone (DHAQ). Chloro-substituted mono- and bis[(aminoalkyl)amino]anthraquinones.
J Med Chem. 1987 Sep;30(9):1682-6. doi: 10.1021/jm00392a028.
4
Structure-activity relationship study of anthraquinones: 1,4-dihydroxy-5,8-bis[[2-(2-hydroxyethoxy)ethyl]amino]-9,10-anthracenedione, an analog of an established antineoplastic agent.蒽醌类化合物的构效关系研究:1,4 - 二羟基 - 5,8 - 双[[2 - (2 - 羟基乙氧基)乙基]氨基] - 9,10 - 蒽二酮,一种已确立的抗肿瘤药物的类似物。
J Pharm Sci. 1982 Jun;71(6):708-9. doi: 10.1002/jps.2600710626.
5
Antitumor properties of tetrahydrobenz[a]anthraquinone derivatives.
J Med Chem. 1990 Feb;33(2):490-2. doi: 10.1021/jm00164a004.
6
2-(1 -hydroxyiminoalkyl)-1 ,4-dimethoxy-9,10-anthraquinones: synthesis and evaluation of cytotoxicity.2-(1-羟基亚氨基烷基)-1,4-二甲氧基-9,10-蒽醌:合成及细胞毒性评估
Arch Pharm Res. 2000 Aug;23(4):283-7. doi: 10.1007/BF02975436.
7
Esters of 2-(1-hydroxyalkyl)-1,4-dihydroxy-9,10-anthraquinones with melphalan as multifunctional anticancer agents.2-(1-羟烷基)-1,4-二羟基-9,10-蒽醌与美法仑的酯类作为多功能抗癌剂。
Bioorg Med Chem Lett. 2001 Jun 4;11(11):1473-6. doi: 10.1016/s0960-894x(01)00260-8.
8
Synthesis and antitumor evaluations of symmetrically and unsymmetrically substituted 1,4-bis[(aminoalkyl)amino]anthracene-9,10-diones and 1,4-bis[(aminoalkyl)amino]-5,8-dihydroxyanthracene-9,10-diones.对称和不对称取代的1,4-双[(氨基烷基)氨基]蒽-9,10-二酮及1,4-双[(氨基烷基)氨基]-5,8-二羟基蒽-9,10-二酮的合成与抗肿瘤评估
J Med Chem. 1991 Aug;34(8):2373-80. doi: 10.1021/jm00112a009.
9
N-(Aminoalkyl)imide antineoplastic agents. Synthesis and biological activity.N-(氨基烷基)酰亚胺类抗肿瘤药。合成与生物活性。
J Med Chem. 1985 Sep;28(9):1216-22. doi: 10.1021/jm00147a016.
10
Potential central nervous system antitumor agents. Aziridinylbenzoquinones.
J Med Chem. 1976 Nov;19(11):1302-8. doi: 10.1021/jm00233a010.

引用本文的文献

1
Dinuclear platinum complexes with N, N'-bis(aminoalkyl)-1,4-diaminoanthraquinones as linking ligands. Part I. Synthesis, cytotoxicity, and cellular studies in A2780 human ovarian carcinoma cells.以N,N'-双(氨基烷基)-1,4-二氨基蒽醌作为连接配体的双核铂配合物。第一部分。A2780人卵巢癌细胞中的合成、细胞毒性及细胞研究
J Biol Inorg Chem. 2004 Jun;9(4):403-13. doi: 10.1007/s00775-004-0539-y. Epub 2004 Apr 8.
2
Mitoxantrone: an active new agent in the treatment of advanced breast cancer.米托蒽醌:治疗晚期乳腺癌的一种新型有效药物。
Cancer Chemother Pharmacol. 1984;12(1):1-4. doi: 10.1007/BF00255899.
3
Correlation of the structure of amino-substituted anthraquinones to cytotoxicity in cultured Chinese hamster cells.氨基取代蒽醌结构与中国仓鼠培养细胞细胞毒性的相关性。
Invest New Drugs. 1983;1(3):213-8. doi: 10.1007/BF00208892.